Jun 192017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MA – Tarveda Therapeutics, Inc., a clinical-stage biopharmaceutical company discovering and developing Pentarins™ as a new class of potent and selective cancer medicines, today announced the appointment of Michael A.=> Read more

Tarveda Therapeutics appoints Michael Metzger to the Board of Directors

From:: Tarveda Therapeutics appoints Michael Metzger to the Board of Directors

Sorry, the comment form is closed at this time.

%d bloggers like this: